LIBROS
Rayssiguier Y, Mazur A, Durlach J, eds. Advances in magnesium research: Nutrition & health. Eastleigh: John Libbey, 2001.
NÚMEROS MONOGRÁFICOS
Gasser JA. Bone anabolic agents. J Musculoeskel Neuron Interact 2001; 2: 1-84.
NUESTROS AUTORES
Hawkins Carranza F. La situación actual de la utilización de la calcitonina en la osteopenia/osteoporosis. Rev Clin Esp 2001; 207: 463-5.
Fiter J, Nolla JM, Gómez-Vaquero C, et al. A comparative study of computed digital absorptiometry and conventional dual-energy X-ray absorptiometry in postmenopausal women. Osteoporosis Int 2001; 12: 565-9.
López-Ibarra PJ, Campos MM, Escobar-Jiménez F, et al. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocrine Pract 2001; 7: 127-31.
Nieto E, Useche R, Natale A. Mortality after hiop fracture in patients > 60 years old. Bone 2001; 29: 303.
Vega E, Mautalen C, Merlo C, Poitevinl L. Bone mineral density in men who have sustained a hip fracture is higher than in women. Bone 2001; 29: 302-2.
Marco-Mingot M, San Millán JL, Wuyts W, et al. Lack of mutations in the RANK gene is Spanish patients with Paget disease of bone. Clin Genet 2001; 60: 86-8.
Ferreira A, Ghazali A, Galvao J, et al. Effect of type of dialysis membrane on bone in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1230-8.
Se ruega a los autores enviar una copia del trabajo para incluir su cita en esta Sección.
REVISIONES
Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship and accountability. N Engl J Med 2001; 345: 825-7.
Sipila S, Taaffe DR, Cheng S, et al. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci 2001; 101: 147-57.
Pierard GE, Pierard-Franchimont C, Vanderplaetsen S, et al. Relationship between bone mass density and tensile strength of the skin in women. Eur J Clin Invest 2001; 31: 731-5.
Wronski TJ. Skeletal effects of systemic treatment with basic fibroblast growth factor. J Musculoeskel Neuron Interact 2001; 2: 9-14.
Hartke JR, Lundy MW. Bone anabolic therapy with selective prostaglandins analogs. J Musculoeskel Neuron Interact 2001; 2: 25-32.
Hinnie J, Bell E, Mckillop E, et al. The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int. 2001; 68: 216-28.
Currey JD. Bone strength: what are we trying to measure? Calcif Tissue Int 2001; 68: 205-10.
Dawson-Hughes B. Bone loss accompanyng medical therapies. N Engl J Med 2001; 345: 989-91.
Stavrou S, Kleinberg DL. Diagnosis and management of growth hormone deficiency in adults. Endocrinol Metab Clin North Am 2001; 30: 545-63.
Perron AD, Brady WJ, Keats TA. Principles of streets fracture management. The whys and hows of an increassingly common injury. Postgad Med 2001; 110: 115-8.
Southerland JC, Valentine JF. Osteopenia and osteoporosis in gastrointestinal diseases: diagnosis and treatment. Curr Gastroenterol Rep 2001; 3: 399-407.
Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev 2001; 12: 361-73.
Nagpal S, Lu J, Boehm MF. Vitamin D analogs: mechanism of action and therapeutic applications. Curr Med Chem 2001; 8: 1679-97.
McCauley LK. Transgenic mouse models of metabolic bone disease. Curr Opin Rheumatol. 2001; 13: 316-25.
Sikavitsas VI, Temenoff JS, Mikos AG. Biomaterials and bone mechanotransduction. Biomaterials 22: 2581-93.
Drueke TB. Genetics aspects of secondary hyperparathyroidism in uremia. Am J Kidney Dis 38: S143-6.
Mundy G. Anabolic agents for osteoporosis. Bone 2001; 29: 295-6.
Canalis E. New treatments in osteoporosis. Bone 2001; 29: 296.
OTROS ARTÍCULOS DE INTERÉS
Hall WD, Pettinger M, Oberman A, et al. Risk factors for kidney stones in older women in the Southern United States. Am J Med Sci 2001; 322: 12-8.
Hogan DB, MacDonald FA, Betts J, et al. A randomized controlled trial of a communnity-based consultation service to prevent falls. CMAJ 2001; 165: 537-43.
Hsieh C, Novielli KD, Diamond JJ, Cheruva D. Health beliefs and attitudes toward the prevention of osteoporosis in older women. Menopause 2001; 8: 372-6.
Juby AG, Davis P. A prospective evaluation of the awareness, knowledge, risk factors and current treatment of osteoporosis in a cohort of elderly subjects. Osteoporosis Int 2001; 12: 617-23.
Voort DJM, Geusens PP, Dinant GJ. Risk factors for the osteoporosis related to their outcome: Fractures. Osteoporosis Int 2001; 12: 630-8.
Chrischilles EA, Dasbach EJ, Rubisnstein LM, et al. The effect of alendronate on fracture-related healthcare utilization and costs: The fracture intervention trial. Osteoporosis Int 2001; 12: 654-60.
Lunt M, Masaryk P, Scheidt C, et al. The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: The EVOS Study. Osteoporosis Int 2001; 12: 688-98.
Damilakis J, Perisinakis K, Gouurtsoyiannis N. Imaging ultrasometry of the calcaneus: optimum T-score thresholds for the identification of osteoporotic subjects. Calcif Tissue Int 2001; 68: 219-24.
Tominaga Y, Uchida K, Haba T, et al. More than 1.000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 2001; 38: 168-71.
Berenson AB, Radecki CM, Grady JJ, et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001; 98: 576-82.
Nuti R, Martini G, Valenti R, et al. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med 2001; 250: 361-16.
Israel E, Banerjee TR, Fitzmaurice GM. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001; 345: 941-7.
Chou FF, Chen JB, Lee CH, et al. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism. Arch Surg 2001; 136: 1064-8.
Schimmer AD, Mah K, Bordeleau L, et al. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant 2001; 28: 387-91.
Curry LC, Hogstel MO. Risk status related to knowledge of osteoporosis in older women. J Women Aging 2001; 13: 71-83.
Seidel C, Hjertner O, Abildgaard N, et al. Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood 2001; 98: 2269-71.
Griffith K, Pearson D, Parker C, et al. The use of a whole body index with bone scintigraphy to mintor the response to theraphy in Paget's disease. Nucl Med Commun. 2001; 22: 1069-75.
Valmadrid C, Voorhees C, Litt B. Practice Patterns of Neurologist Regarding Bone and Mineral Effects of Antiepileptic Drug Therapy. Arch Neurol 2001; 58: 1369-74.
Goemaere S, Van Pottelberg I, Zmierczak H, et al. Inverse association between bone turnover rate and bone mineral density in community-dwelling men > 70 years of age: no major role of sex steroid status. Bone 2001; 29: 286-91.
Bord S, Beavan S, Ireland D. Mechanism by wich high-dose estrogen theraphy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors. Bone 2001; 29 (3): 216-22.
PREMIOS AL MEJOR TRABAJO EN REEMO 2001
EDICIONES DOYMA, S.A.
CONVOCA
LOS PREMIOS AL MEJOR TRABAJO ORIGINAL Y AL MEJOR TRABAJO CLÍNICO PUBLICADOS EN LA REVISTA ESPAÑOLA DE ENFERMEDADES METABÓLICAS ÓSEAS DURANTE EL AÑO 2001
1. Concurren a él todos los trabajos originales y clínicos publicados en la REVISTA ESPAÑOLA DE ENFERMEDADES METABÓLICAS ÓSEAS, durante el año 2001.
2. El Consejo Editorial realizará para cada grupo una selección de los tres mejores trabajos.
3. El Comité Editorial posteriormente otorgará un premio de 100.000 ptas, acompañado de un diploma, al mejor trabajo de cada grupo. El premio será entregado al primer firmante del trabajo.
4. Las decisiones de los Jurados responderán a criterios de independencia y de objetividad.
5. El resultado será hecho público en la VII Reunión SEIOMM de 2002.